Premium 5
Premium 6
Premium Domains
Premium 2
Premium 3
Premium 4
Rare domains
cities_realestate
Similar   Websites
education_sites
entertainment_sites
games
misc_sites
LLLL.com Site
Acronym 2
Acronym 4
Acronym 5
Acronym 6
Acronym 7
Acronym 8
Acronym 9
Acronym 10
Acronym 3
Brandable sites
Pin Yin sites
service_sites
technology
Acronym sites
Payment Options
About Our Office

Acronym Definition
BILR Brother-In-Law Response
BILR Band Interleaved by Line Recording
BILR Basic Impulse Level (electrical power switches) Resource
BILR Basic Insulation Level (IEC) Resource
BILR Bharti Infotel Resource
BILR Bilateral Reconcile
BILR Billings, MT, USA - Billings Logan Intnl Airport (Airport Code) Resource
BILR Billion Resource
BILR Biocon India Limited Resource
BILR Blue Indicating Light Resource
BILR Built-In Logic Resource
BILR Business Importance Level Resource


 

BILR

However, NNRTIs have an Achilles' heel: cross resistance. The cross resistance that exists between the currently available NNRTIs -- nevirapine (NVP, Viramune), delavirdine (DLV, Rescriptor) and efavirenz (EFV, Sustiva, Stocrin) -- gives patients and practitioners only one shot at the use of this class of drugs. As patients live longer on HAART and the pool of NNRTI-resistant viruses increases, so does the need for the development of new, second-generation NNRTIs with antiviral activity against both wild-type and the clinically prevalent NNRTI-resistant strains.

E. Wardrop from Boehringer Ingelheim presented in vitro data on BILR 355 BS, an NNRTI in development that has potent in vitro antiviral activity against a wide range of recombinant NNRTI-resistant viruses (EC50 < 10 nM). Past research has shown excellent pharmacokinetic and safety characteristics for this drug in small phase 1 trials in healthy volunteers.1 Initial studies with viruses resistant to currently available NNRTIs also support its continued development.2 The study presented by Wardrop at this conference further explored the mutational pathways that may reduce a patient's susceptibility to BILR 355 BS. Clade B HIV virus, the most common clade in the developed world, was examined, as were the non-clade B viruses found in the developing world. In addition, HIV-1 groups M and O, as well as HIV-2, were all tested for susceptibility to BILR 355 BS.

Wild-type and NNRTI-resistant HIV-1 were passaged in C8166 cells in the presence of BILR 355 BS. Inhibition of both wild-type and NNRTI-resistant virus containing emergent reverse transcriptase (RT) mutations was determined by p24 antigen assay.

Viral replication capacities were determined by luciferase expression in infected Jurkat-LTR-luciferase cells. ViroLogic PhenoSense methodology or p24 antigen assay was used to determine BILR 355 BS's antiviral activity against a panel of clinical isolates of wild-type group M HIV-1 (including clades A, B, C, D, F, G and H) and HIV-2. All clinical isolates were from treatment-naive patients, in order to minimize the potential for treatment-emergent resistance mutations. Group O isolates harbor naturally occurring polymorphisms, which may confer NNRTI resistance.

The chart below displays the antiviral profile of BILR 355 BS against recombinant viruses harboring the most commonly observed clinical resistance mutations. The data show that these mutations generally have a minimal impact on BILR 355 BS compared to nevirapine and efavirenz (mutations with minimal impact compared to wild-type virus are shown in bold). However, reduced susceptibility was seen with the Y188L and Y181C/ G190A mutations
 

RuneScape is a Java-based MMORPG operated by Jagex Ltd. With over nine million active free accounts and more than one million paid member accounts, RuneScape is rated among the most popular online games in the world. More than five million unique players access their accounts to play RuneScape at least once per month. RuneScape offers both free and subscription content and is designed to be accessible from any location with an Internet connection and to run in an ordinary web browser without straining system resources. One of the best website that discussed various gamers' issues is IJFG.com IJFG.COM Internet Junction For Gamers  Internet Junction For Gamers, Runescape Market and More IJFG.COM This site has Jokes, Pranks, Runescape and other cool games at IJFG.COM. RuneScape is set in a medieval fantasy world, similar to "Guild Wars" or "EverQuest", where players control character representations of themselves. As with most massive multiplayer online roleplaying games (MMORPG), there is no overall objective or end to the game. Players explore, form alliances, perform optional tasks, and complete quests for rewards and to build character's skills.  Internet Junction For Gamers, Runescape Market and More. IJFG.com IJFG.com RuneScape takes place in the fantasy-themed realm of Gielinor, which is divided into several different kingdoms, regions, and areas. Players can travel throughout the gaming world on foot, by using magical teleportation spells or devices, or mechanical means of transportation. Each region offers different types of monsters, materials, and quests to challenge players. Players are shown on the screen as customisable avatars. They set their own goals and objectives, deciding which of the available activities to pursue. There is no linear path that must be followed. Players can engage in combat with other players or with monsters, complete quests, or increase their experience in any of the available skills. Players interact with each other through trading, chatting, or playing combative or cooperative mini-games. Internet Junction For Gamers, Runescape Market and More IJFG.COM IJFG.com

Contact Information

Call our office today to set up an appointment. Learn more about how we can help you, and learn more about the other services that we can offer you. All messages we receive will be answered as soon as possible. We look forward to hearing from you.

Electronic mail

General Information:
 

Copyright © 2007 bilr.com                    Powered by Engineer Partner The One Stop Outsource